investorscraft@gmail.com

Intrinsic ValueUniversal Health Realty Income Trust (UHT)

Previous Close$39.73
Intrinsic Value
Upside potential
Previous Close
$39.73

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Universal Health Realty Income Trust (UHT) is a real estate investment trust (REIT) specializing in healthcare-related properties, including hospitals, medical office buildings, and acute care facilities. The company generates revenue primarily through long-term triple-net leases, ensuring stable cash flows with contractual rent escalations. UHT operates in a defensive sector, benefiting from the essential nature of healthcare services, which provides resilience against economic downturns. Its portfolio is strategically diversified across the U.S., with tenants often affiliated with reputable healthcare systems, reinforcing occupancy stability. The REIT’s focus on mission-critical properties positions it as a low-risk player in the healthcare real estate market, appealing to income-focused investors. UHT’s conservative lease structures and high tenant retention underscore its competitive advantage in a fragmented industry.

Revenue Profitability And Efficiency

In FY 2024, UHT reported revenue of $99.0 million, with net income of $19.2 million, translating to diluted EPS of $1.39. Operating cash flow stood at $46.9 million, reflecting strong cash generation from its lease-heavy model. The absence of capital expenditures highlights its asset-light approach, as property maintenance responsibilities typically fall to tenants under triple-net leases.

Earnings Power And Capital Efficiency

UHT’s earnings are underpinned by predictable rental income, with minimal variability due to long-term leases. The REIT’s capital efficiency is evident in its ability to fund dividends and debt obligations entirely from operating cash flow. Its fixed-cost structure and high-margin lease revenue contribute to consistent profitability, though leverage metrics warrant monitoring given its $379.2 million total debt.

Balance Sheet And Financial Health

UHT maintains a conservative balance sheet with $7.1 million in cash and equivalents against $379.2 million in total debt. The REIT’s leverage is mitigated by its stable cash flows, but interest coverage remains a focus. Its debt-to-equity ratio aligns with sector norms, though refinancing risks could arise in a higher-rate environment.

Growth Trends And Dividend Policy

UHT’s growth is driven by accretive acquisitions and contractual rent hikes, though its portfolio expansion has been measured. The REIT offers a robust dividend yield, with $2.93 per share distributed annually, supported by a payout ratio of approximately 90% of AFFO. Dividend sustainability hinges on maintaining occupancy and lease renewals.

Valuation And Market Expectations

UHT trades at a premium to book value, reflecting investor confidence in its healthcare-focused strategy. Market expectations are anchored to steady rental income growth, though valuation multiples may face pressure if interest rates remain elevated. The REIT’s yield appeal balances its moderate growth prospects.

Strategic Advantages And Outlook

UHT’s strategic focus on healthcare real estate provides insulation from cyclical risks, while its triple-net leases ensure operational simplicity. The REIT is well-positioned to benefit from aging demographics and healthcare demand tailwinds. However, its outlook depends on prudent capital allocation and maintaining tenant credit quality in a competitive leasing environment.

Sources

10-K filing, company investor relations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount